Dr. Chandler Park discusses the importance of genetic testing and personalized care in patients with genitourinary cancers.
OS Therapies, Inc., a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, announced that it received a Notice of Allowance from the United ...